Scribe Therapeutics raises a $129.0M Other round
Other
$129.0M
Round details
- Company
- Scribe Therapeutics
- HQ
- US
- Stage
- Other
- Amount
- $129.0M
- Website
- www.scribetx.com/
- Source
- Announcement
Scribe is enabling the creation of genetic medicines through its CRISPR by Design™ approach to genetic modification.